Literature DB >> 28104102

Inhibition of Focal Adhesion Kinase on Hepatic Stellate-cell Adhesion and Migration.

Yan Wang1, Junji Ma1, Lei Chen1, Xiao-Li Xie1, Huiqing Jiang2.   

Abstract

OBJECTIVE: Hepatic fibrosis is characterized by the activation of hepatic stellate cells (HSCs). Focal adhesion kinase (FAK)-phosphatidylinositol 3-kinase (PI3K) signals participate in the activation of HSCs. We evaluated the effect of FAK-related nonkinase (FRNK) on the adhesion and migration of HSCs.
MATERIALS AND METHODS: Hepatic fibrosis was induced in Sprague-Dawley rats by means of bile duct ligation. Livers were harvested at 1, 2, 3 and 4 weeks after the ligation; livers of sham-operated animals were harvested at 4 weeks after ligation. Histopathologic features were evaluated in liver sections stained with hematoxylin-eosin and Sirius Red stain. HSCs were transfected with FRNK plasmid. The adhesion of HSCs was examined with a toluidine blue colorimetric assay. The migration of HSCs was evaluated by the use of an improved Boyden double-chamber method. Protein and messenger RNA levels in the liver and the HSCs were determined by Western blot analysis and real-time polymerase chain reaction, respectively.
RESULTS: Hematoxylin-eosin staining of the liver documented the presence of fibrosis in the rats. Actin and PI3K expression was increased in parallel with the development of hepatic fibrosis. At the same time, activator protein-1 (AP-1) (c-fos, c-jun) mRNA in the livers was increased. Overexpression of FRNK inhibited the adhesion and migration of HSCs time-dependently. Simultaneously, FRNK inhibited PI3K mRNA and protein expression and c-jun mRNA expression.
CONCLUSIONS: FRNK inhibited the adhesion and migration of HSCs by decreasing the expressions of the FAK-PI3K-AP-1 signal pathway.
Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adhesion; Focal adhesion kinase–related nonkinase; Hepatic stellate cells; Migration; Phosphatidylinositol 3-kinase

Mesh:

Substances:

Year:  2016        PMID: 28104102     DOI: 10.1016/j.amjms.2016.11.020

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis.

Authors:  Yitong Zhang; Jing Liu; Yanyun Ma; Jingjie Wang; Jie Zhu; Jie Liu; Jun Zhang
Journal:  Mol Med Rep       Date:  2018-11-09       Impact factor: 2.952

2.  Screening and evaluation of key genes in contributing to pathogenesis of hepatic fibrosis based on microarray data.

Authors:  Furong Wu; Lijuan Ning; Ran Zhou; Aizong Shen
Journal:  Eur J Med Res       Date:  2020-09-17       Impact factor: 2.175

3.  Profiles of messenger RNAs and MicroRNAs in hypoxia-induced hepatic stellate cells.

Authors:  Liting Zhang; Jing Gao; Dan Zhou; Xiaojun Wang; Junfeng Li; Juan Wang; Hong Chen; Xiaodong Xie; Tuo Chen
Journal:  Ann Transl Med       Date:  2021-09

4.  Genome‑wide identification of long noncoding RNAs in CCl4‑induced liver fibrosis via RNA sequencing.

Authors:  Zhenghua Gong; Jialin Tang; Tianxin Xiang; Jiayu Lin; Chaowen Deng; Yanzhong Peng; Jie Zheng; Guoxin Hu
Journal:  Mol Med Rep       Date:  2018-05-07       Impact factor: 2.952

5.  The Phenylethanol Glycoside Liposome Inhibits PDGF-Induced HSC Activation via Regulation of the FAK/PI3K/Akt Signaling Pathway.

Authors:  Shi-Lei Zhang; Long Ma; Jun Zhao; Shu-Ping You; Xiao-Ting Ma; Xiao-Yan Ye; Tao Liu
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.